期刊文献+

RP-HPLC法测定凡德他尼片中主药和有关物质的含量

Content Determination of Main Components and Related Substances in Vandetanib Tablets by RP-HPLC
原文传递
导出
摘要 目的:建立测定凡德他尼片中主药和有关物质含量的方法。方法:采用反相高效液相色谱法。色谱柱为KromasilC18,流动相为0.05mol·L-1醋酸铵缓冲液-甲醇(30∶70,pH8.0),流速为1.0mL·min-1,检测波长为247nm,进样量为20μL。结果:凡德他尼检测浓度的线性范围为20.05~180.4μg·mL-(1r=0.9999);平均回收率为99.40%(RSD=0.56%),定量限为4ng。结论:本方法操作简便、快捷,结果准确、可靠,可用于凡德他尼片的质量控制。 OBJECTIVE: To establish a method for the content determination of main components and related substances in Vandetanib tablets. METHODS: RP-HPLC method was adopted. The determination was performed on Kromasil C18 column with mobile phase consisted of 0.05 mol·L^-1 acetate buffer-methanol (30:70, adjusting pH to 8.0) at the flow rate of 1.0 mL·min^-1. The detection wavelength was set at 247 nm and injection volume was 20 μL. RESULTS: The linear range of vandetanib was 20.05-180.4μg·mL^-1(r=0.999 9) with an average recovery of 99.40% (RSD=0.56%), and LOQ was 4 ng. CONCLUSION: The method is simple, rapid, accurate and reliable, and it is applicable for the quality control of Vandetanib tablets.
出处 《中国药房》 CAS CSCD 2012年第29期2759-2760,共2页 China Pharmacy
关键词 凡德他尼片 反相高效液相色谱法 有关物质 含量测定 Vandetanib tablet RP-HPLC Related substance Content determination
  • 相关文献

参考文献1

  • 1FDA. FDA approves new treatment for rare form of thyro- id eancer[EB/OL], http://www.fda.gov/NewsEvents/New- sroom/PressAnnouneements/ucm250168.htm. 2011-04- 06.2011-08-16.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部